STAT Plus: Trump administration proposes a dramatic payment boost for CAR-T treatments under Medicare
WASHINGTON — The Centers for Medicare and Medicaid Services proposed a major payment bump for hospitals administering the cutting-edge gene therapies known as CAR-T treatments late Monday.
It’s a direct response to longstanding criticisms from the pharmaceutical industry, patient advocates, and hospitals that said Medicare’s subpar reimbursement rates for the new therapies — which can have list prices upward of $450,000 per patient — forced hospitals to choose between losing money or declining to offer the therapies at all.
